Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer

Description

The purpose of this study is to determine how the STRONG intervention compares with usual care for reducing malnutrition among gastroesophageal cancer patients.

Conditions

GastroEsophageal Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to determine how the STRONG intervention compares with usual care for reducing malnutrition among gastroesophageal cancer patients.

Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer (STRONG-GEC)

Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer

Condition
GastroEsophageal Cancer
Intervention / Treatment

-

Contacts and Locations

Tampa

Moffitt Cancer Center, Tampa, Florida, United States, 33612

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Participants must be 18 years of age or older
  • * Participants must have locally advanced or metastatic gastroesophageal cancer (GEC)
  • * Participants must plan to initiate chemotherapy and/or radiation therapy with a plan to have surgery or definitive treatment follow up at Moffitt
  • * Participants must be able to speak and read Spanish and/or English
  • * Participants must be able to provide informed consent
  • * Participants have a documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g. severe dementia)
  • * Use of feeding tubes at the time of study enrollment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

H. Lee Moffitt Cancer Center and Research Institute,

Kea Turner, PhD, MA, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Jose Pimiento, MD, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

2027-06